*************   P   R   O   G   R   A   M       H   E   A   D   E   R   *****************
*****************************************************************************************
*                                                                                       *
*   PROJECT:    CAPSTONE                                                                *
*   AUTHOR:     LAURA GRAU 	                                                            *
*   CREATED:    2017-09-24                                                              *
*                                                                                       *
*   DATA USED:  HALTPKD                                                      			*
*   SOFTWARE:   SAS (r) Proprietary Software 9.4 (TS1M4)                                *                                                   
*                                                                                       *
*****************************************************************************************
***********************************************************************************; RUN;
/* ANALYSIS PLAN
1.	ANOVA Vitamin D according to PKD Mutation
2.	ANOVA FGF23 according to PKD Mutation
3.	Figure out proper significance level (Tukeyâ€™s adjustment?)
4.	Crude Models of each covariate with outcomes
5.	Significant Covariates go into final models
Decline in eGFR= genotype + FGF23 + Mineral Metabolites+ Demographics
% increase in htTKV= genotype + FGF23 + Mineral Metabolites+ Demographics

*/